Physician profile
Neeru Dua
NPI 1881666881
$3,666.70
in general payments reported to CMS, 2019-2025
15 companies · $887 in 2025
The $887 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $146 · 2021: $379 · 2022: $984 · 2023: $550 · 2024: $507 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,944.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,456.49 | 2022-2025 | Vuity, Xen Glaucoma Treatment System, Alphagan P |
| Allergan, INC. | $688.88 | 2019-2022 | |
| Alcon Vision LLC | $433.35 | 2019-2025 | Rocklatan, Rhopressa, Clareon |
| Sun Pharmaceutical Industries INC. | $286.10 | 2019-2024 | Cequa |
| Sight Sciences, INC. | $206.27 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $169.76 | 2022-2025 | Vyzulta |
| Johnson & Johnson Surgical Vision, INC. | $126.84 | 2024 | Tecnis Simplicity |
| Medtronic, INC. | $123.75 | 2022 | |
| Rayner Intraocular Lenses Limited | $36.10 | 2022-2025 | Omidria |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.83 | 2021 | |
| Eyevance Pharmaceuticals LLC | $28.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.93 | 2023 | |
| Aerie Pharmaceuticals, INC. | $21.03 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $19.12 | 2024 | Xdemvy |
| Dompe US, INC. | $13.69 | 2025 | Oxervate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeru Dua listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.